# Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren

> **NCT01722539** · PHASE3 · COMPLETED · sponsor: **Universiteit Antwerpen** · enrollment: 616 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Sulfadoxine-pyrimethamine
- **DRUG:** Piperaquine
- **DRUG:** Albendazole
- **DRUG:** Praziquantel

## Key facts

- **NCT ID:** NCT01722539
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 616 (ACTUAL)
- **Last updated:** 2014-02-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01722539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01722539, "Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren". Retrieved via MORVS 2026-11-19 from https://api.morvs.ai/clinical/NCT01722539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
